ENvue Medical, Inc.

8-K Director or officer change Jul 14, 2026 8-K Delisting notice or listing-rule failure Jul 10, 2026 10-Q Quarter ended 2026-03-31 May 18, 2026 10-K Fiscal year ended 2025-12-31 Apr 15, 2026 8-K Director or officer change Feb 6, 2026 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws Jan 30, 2026 8-K Director or officer change Dec 30, 2025 8-K Director or officer change Dec 23, 2025 8-K Amended charter or bylaws; Regulation FD disclosure Dec 12, 2025 8-K Director or officer change; Shareholder vote results Dec 5, 2025 8-K Regulation FD disclosure Nov 19, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Director or officer change Oct 30, 2025 8-K Entered a material agreement; Other events Sep 17, 2025 10-Q Quarter ended 2025-06-30 Aug 19, 2025 8-K Changed accountants; Director or officer change Aug 14, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Other events Aug 8, 2025 8-K Director or officer change Jul 30, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws Jul 22, 2025 8-K Shareholder vote results Jul 18, 2025 8-K Other events Jul 11, 2025 8-K Modified rights of security holders; Amended charter or bylaws Jul 9, 2025 8-K Director or officer change; Other events Jun 4, 2025 10-Q Quarter ended 2025-03-31 May 20, 2025 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws; Other events May 16, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Other events Apr 11, 2025 8-K Director or officer change Apr 3, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Regulation FD disclosure Mar 14, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Other events Mar 12, 2025 8-K Shareholder vote results Feb 25, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws; Regulation FD disclosure Feb 14, 2025 8-K Unregistered sale of equity Jan 7, 2025 8-K Regulation FD disclosure; Other events Jan 6, 2025 8-K Director or officer change; Shareholder vote results Dec 20, 2024 8-K Regulation FD disclosure Dec 19, 2024 8-K Other events Dec 11, 2024 8-K Delisting notice or listing-rule failure Nov 22, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Delisting notice or listing-rule failure Oct 11, 2024